Posters
« Back
GC-MS/MS ANALYSIS OF BENZODIAZEPINES USING ANALYTE PROTECTANTS
EP21991
Poster Title: GC-MS/MS ANALYSIS OF BENZODIAZEPINES USING ANALYTE PROTECTANTS
Submitted on 10 Jun 2014
Author(s): Jeremy Matthews, Alex Chen, Flavio Bedini
Affiliations: Thermo Fisher Scientific
Poster Views: 3,126
View poster »


Poster Information
Abstract: Benzodiazepines drugs are psychoactives whose structure contains a benzene ring fused with a diazepine ring. One of the most well known benzodiazepines – diazepam – has been marketed under the name “Valium” since 1963. These drugs are effective tranquilizers and as such are commonly used in medication to treat anxiety and sleep disorders amongst other conditions. The relative availability of these drugs combined with their sedative effect has led to their illicit use as either recreational drug and sometimes in suicides. Consequently it is common practice to analyze for benzodiazepines in forensic and toxicology laboratories.
Benzodiazepines compounds are bases and so readily react with active sites in eg. the GC inlet liner causing problems in analysis at low levels and resulting in poor linearity and reproducibility. The use of analyte protectants reduces liner activity and often enables the detection of such ‘active’ compounds at much lower levels. The use of analyte protectants in the GCMS analysis of a group of benzodiazepines was investigated and the results are discussed below.
Summary: Purpose: Assess the feasibility of using analyte protectants to improve the analysis of benzodiazepines.
Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Wavefunction Stability Determination
Tylor

Computational Planning of Synthesis of Natural Products
Tylor

Neurodegeneration quantitative systems pharmacology modeling for analysis of multiple sclerosis therapy
Polina Pchelintseva, Anna Mishina, Tatiana Karelina

Retrosynthetic Route Planning Based on Molecular Similarity
Tylor

Prediction of intratumoral TIGIT receptor occupancy after the treatment with anti-TIGIT antibodies
Dmitry Shchelokov (1), Oleg Demin Jr (1), Oleg Demin (1), Ahsan Rizwan (2), Yun Zhang (3), Wei Tan (4), Srikumar Sahasranaman (2), Nageshwar Budha (2)